Geoffrey M Parker

Geoffrey M Parker

CFO · Allogene Therapeutics, Inc.

Rank #15,029 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyALLOSEC CIK 0001491874

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$3.5M
1-day change
▲ 0.98%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$2.5M – $4.4M2026-09-04

Insider activity May 15, 2024 – Feb 2, 2026

Geoffrey M Parker is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 13 transactions between May 15, 2024 and Feb 2, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$301.7K
3 purchases on file priced rows only
Open-market sales (code S)
$96.1K
3 sales on file priced rows only
All reported transactions
13
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought PERRIGO Co plc (PRGO) shares worth $268,487 between Aug 8, 2025 and Aug 18, 2025

Cluster buying

3 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought PERRIGO Co plc (PRGO) shares worth $268,487 between Aug 8, 2025 and Aug 18, 2025
Date Insider Transaction Shares Price Value Filing
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 346 held after: 85,758 $22.38 $7,743 SEC filing ↗
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 4,060 held after: 85,412 $22.37 $90,822 SEC filing ↗
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 54 held after: 85,812 $22.37 $1,208 SEC filing ↗
Aug 18, 2025 Geoffrey M Parker P Open-market purchase 4,375 held after: 9,875 $22.97 $100,494 SEC filing ↗
Aug 18, 2025 Eduardo Guarita Bezerra P Open-market purchase 3,000 held after: 48,949 $22.74 $68,220 SEC filing ↗

Total of the rows above: $268,487, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 17 most recent rows are grouped into 17 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 469 shares $5.2K at $10.99 SEC filing ↗
  2. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 976 shares $10.7K at $10.99 SEC filing ↗
  3. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 3,507 shares $38.0K at $10.84 SEC filing ↗
  4. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 7,305 shares $79.2K at $10.84 SEC filing ↗
  5. Allogene Therapeutics, Inc. ALLO S Open-market sale 24,001 shares $42.2K at $1.76 SEC filing ↗
  6. PERRIGO Co plc PRGO P Open-market purchase 7,500 shares $106.4K at $14.18 SEC filing ↗
  7. Allogene Therapeutics, Inc. ALLO S Open-market sale 36,744 shares $46.3K at $1.26 SEC filing ↗
  8. PERRIGO Co plc PRGO P Open-market purchase 4,375 shares $100.5K at $22.97 SEC filing ↗
  9. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 9,904 shares $257.6K at $26.01 SEC filing ↗
  10. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 4,754 shares $123.7K at $26.01 SEC filing ↗
  11. PERRIGO Co plc PRGO P Open-market purchase 3,500 shares $94.9K at $27.10 SEC filing ↗
  12. Allogene Therapeutics, Inc. ALLO S Open-market sale 4,361 shares $7.5K at $1.73 SEC filing ↗
  13. Allogene Therapeutics, Inc. ALLO A Grant or awardnot a buy/sell decisionreported at zero 173,913 shares $0 at $0.00 SEC filing ↗
  14. Allogene Therapeutics, Inc. ALLO F Shares withheld for taxesnot a buy/sell decision 36,404 shares $103.4K at $2.84 SEC filing ↗
  15. Allogene Therapeutics, Inc. ALLO A Grant or awardnot a buy/sell decision 344,828 shares $1.00M at $2.90 SEC filing ↗
  16. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 4,207 shares $127.1K at $30.22 SEC filing ↗
  17. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 8,764 shares $264.8K at $30.22 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Allogene Therapeutics, Inc. ALLO Common Stock 1,252,795 $1.97 $2.5M 4 EDGAR ↗
PERRIGO Co plc PRGO Ordinary Shares (indirect) 72,166 $14.92 $1.1M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Geoffrey M Parker reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: PERRIGO Co plc (company-published photograph). Original file page on investor.perrigo.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.